Synergy of radiotherapy and PD-1 blockade in Kras-mutant lung cancer
Grit S. Herter-Sprie(Harvard University), Kwok‐Kin Wong(Brigham and Women's Hospital)
Cited by 158
Related Papers
Multiparametric profiling of non–small-cell lung cancers reveals distinct immunophenotypes
|JCI Insight|2016|127
Lkb1 inactivation drives lung cancer lineage switching governed by Polycomb Repressive Complex 2
|Nature Communications|2017|120
D-2-hydroxyglutarate produced by mutant IDH2 causes cardiomyopathy and neurodegeneration in mice
|Genes & Development|2014|86
Therapeutic anti-EGFR antibody 806 generates responses in murine de novo EGFR mutant–dependent lung carcinomas
|Journal of Clinical Investigation|2007|56
Image-guided radiotherapy platform using single nodule conditional lung cancer mouse models
|Nature Communications|2014|53